Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2024416. doi: 10.1080/21645515.2021.2024416. Epub 2022 Feb 7.
Hum Vaccin Immunother. 2022.
PMID: 35130105
Free PMC article.
CIMT 2018: Pushing frontiers in cancer immunotherapy - Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy.
Beck J, Birtel M, Reidenbach D, Salomon N, Diken M.
Beck J, et al. Among authors: reidenbach d.
Hum Vaccin Immunother. 2018;14(12):2864-2873. doi: 10.1080/21645515.2018.1504526. Epub 2018 Aug 29.
Hum Vaccin Immunother. 2018.
PMID: 30111232
Free PMC article.
Item in Clipboard
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy.
Beck JD, Birtel M, Haefner E, Keil IS, Reidenbach D, Salomon N, Yildiz IG, Diken M.
Beck JD, et al. Among authors: reidenbach d.
Hum Vaccin Immunother. 2020 Apr 2;16(4):808-815. doi: 10.1080/21645515.2019.1675459. Epub 2019 Nov 11.
Hum Vaccin Immunother. 2020.
PMID: 31584850
Free PMC article.
No abstract available.
Item in Clipboard
mRNA therapeutics in cancer immunotherapy.
Beck JD, Reidenbach D, Salomon N, Sahin U, Türeci Ö, Vormehr M, Kranz LM.
Beck JD, et al. Among authors: reidenbach d.
Mol Cancer. 2021 Apr 15;20(1):69. doi: 10.1186/s12943-021-01348-0.
Mol Cancer. 2021.
PMID: 33858437
Free PMC article.
Review.
Item in Clipboard
PeakVI: A deep generative model for single-cell chromatin accessibility analysis.
Ashuach T, Reidenbach DA, Gayoso A, Yosef N.
Ashuach T, et al. Among authors: reidenbach da.
Cell Rep Methods. 2022 Mar 15;2(3):100182. doi: 10.1016/j.crmeth.2022.100182. eCollection 2022 Mar 28.
Cell Rep Methods. 2022.
PMID: 35475224
Free PMC article.
Item in Clipboard
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.
Pickl JM, Tichy D, Kuryshev VY, Tolstov Y, Falkenstein M, Schüler J, Reidenbach D, Hotz-Wagenblatt A, Kristiansen G, Roth W, Hadaschik B, Hohenfellner M, Duensing S, Heckmann D, Sültmann H.
Pickl JM, et al. Among authors: reidenbach d.
Oncotarget. 2016 Sep 13;7(37):59589-59603. doi: 10.18632/oncotarget.10729.
Oncotarget. 2016.
PMID: 27449098
Free PMC article.
Item in Clipboard
Cite
Cite